fda semaglutide warning september 2025 What Patients Need to Know About the GLP-1 Policy Changes FDA Issues Warning Letters to

Recognizing obesity as a medical condition rather than a cosmetic issue is essential to ensuring equitable access

If needle anxiety is present, apply a topical numbing cream (such as lidocaine) to the injection site 10 minutes before injecting and allow it to dry completely

The answer might depend on the individual, their age or health status, or what they are using the drug for

Semaglutide is given once per week on the same day each week as a subcutaneous (under the skin) injection

[email protected] | www

This makes semaglutide a potentially powerful tool for weight management, particularly in individuals who struggle with obesity or have weight-related health conditions